The Effects of Kinesio Taping on Hallux Valgus (NCT07589829) | Clinical Trial Compass
CompletedNot Applicable
The Effects of Kinesio Taping on Hallux Valgus
Turkey (Türkiye)50 participantsStarted 2024-12-25
Plain-language summary
Purpose: The purpose of this study is to evaluate the clinical, radiological, and biomechanical effects of Kinesio Taping (KT) when integrated into a standard exercise program for individuals with Hallux Valgus (HV). Hallux valgus is a progressive deformity of the first metatarsophalangeal (MTP) joint that leads to pain, functional impairment, and gait disturbances. While conservative treatments like exercises are common, the specific impact of KT on dynamic plantar pressure distribution and radiological angles requires further objective evidence.
Methods: A total of 50 participants (aged 18-65) with mild-to-moderate HV are randomized into two groups. Group 1 receives a 4-week intervention consisting of specialized Kinesio Taping applied once a week plus a daily home exercise program. Group 2 performs the same home exercise program only.
Assessments: Assessments include radiological measurements (Hallux Valgus Angle - HVA and Intermetatarsal Angle - IMA), clinical pain levels via the Visual Analog Scale (VAS), functional status via the American Orthopaedic Foot and Ankle Society (AOFAS-MTP-IP) scale, and dynamic pedobarographic analysis using the Zebris® FDM-2 system. Physical exercise capacity is also measured by the 6-Minute Walk Test (6MWT).
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Women and men between the ages of 18-65
* People with mild or moderate stage hallux valgus
* People with VAS 3 and above
Exclusion Criteria:
* Neuromuscular diseases that limit clinical exercise, uncontrolled psychiatric diseases or cognitive-cognitive disorders
* Patients who have received physiotherapy to the foot area in the last 6 months
* Presence of uncontrolled systemic diseases
* Malignancy
* Infection
* High fever
* Acute inflammatory rheumatic diseases
* Acute peripheral vascular diseases
* Patients with previous foot surgery
* Patients with skin lesions in the foot area
* Patients with rheumatoid arthritis
* Patients without cooperation and compliance
* Patients who did not agree to participate in the study
* Patients with foot osteoarthritis
* Patients with gouty arthritis
* Patients allergic to kinesio tape material
* Patients with hallux rigidus
* Other lower extremity alignment disorders (genu varum/valgum, developmental hip dysplasia etc.)
* People who have a history of using foot orthosis
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.